Provider Profile:
Elisabeth Heath, M.D., FACP

• Adrenal Cancer
• Bladder Cancer
• Kidney (Renal Cell) Cancer
• Penile (Penis) Cancer
• Prostate Cancer
• Testicular Cancer
• Ureter Cancer
• Urethral Cancer

School

• Jefferson Medical College

Residency

• Georgetown University School of Medicine and Hospital, Washington, DC

Fellowships

• Medical Oncology Fellowship: Johns Hopkins School of Medicine and Hospital, Baltimore, MD

Awards

• 2010-2023 Detroit's Top Doctors, Hour Magazine
• 2011 Blue Cross Blue Shield of Michigan Foundation, McDevitt Excellence in Research Award
• 2011 Wayne State University, Physician Golden Heart Faculty Award
• 2010 NCI Cancer Clinical Investigator Team Leadership Award
• 2011 The Spirit of Detroit Award

Professional Memberships

• America Society of Clinical Oncology
• American Association for Cancer Research
• Southwest Oncology Group

• First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemother Pharmacol. 2011 Oct 22. PMID: 22020315Authors: Chung V, Heath EI, Schelman WR, Johnson BM, Kirby LC, Lynch KM, Botbyl JD, Lampkin TA, Holen KD.
• A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors. Invest New Drugs. 2011 Aug 3. PMID: 21799472Authors: Heath EI, Forman K, Malburg L, Gainer S, Suttle AB, Adams L, Ball H, Lorusso P.
• Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction. Anticancer Drugs. 2011 Sep;22(8):794-800. PMID: 21799472 Authors: Gupta S, Parsa V, Heilbrun LK, Smith DW, Dickow B, Heath E, Vaishampayan
• Inhibition of HDAC1 by Maspin Abrogates Epigenetic Silencing of Glutathione S-Transferase Pi (GSTp) in Prostate Carcinoma Cells. Mol Cancer Res. 2011 May 26. PMID: 21622623 Authors: Li X, Kaplun A, Lonardo F, Heath EI, Sakr FH, Irish J, Sakr WA, Sheng S.
• Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience. J Geriatr Oncol. 2011 Jan 1;2(1):18-24. PMID: 21503272 Authors: Zafar SF, Heilbrun LK, Vishnu P, Jasti P, Venkatramanamoorthy R, Ding L, Lorusso PM, Heath EI.